monoisoamyl-2,3-dimercaptosuccinate has been researched along with monensin in 1 studies
Studies (monoisoamyl-2,3-dimercaptosuccinate) | Trials (monoisoamyl-2,3-dimercaptosuccinate) | Recent Studies (post-2010) (monoisoamyl-2,3-dimercaptosuccinate) | Studies (monensin) | Trials (monensin) | Recent Studies (post-2010) (monensin) |
---|---|---|---|---|---|
53 | 0 | 19 | 3,336 | 115 | 424 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dubey, M; Flora, SJ; Kushwaha, P; Pachauri, V; Yadav, A | 1 |
1 other study(ies) available for monoisoamyl-2,3-dimercaptosuccinate and monensin
Article | Year |
---|---|
Monensin potentiates lead chelation efficacy of MiADMSA in rat brain post chronic lead exposure.
Topics: Animals; Antioxidants; Biomarkers; Brain; Chelating Agents; DNA Damage; Glutathione; Glutathione Disulfide; Glutathione Peroxidase; Kidney; Lead; Male; Monensin; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Succimer; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2012 |